Navigation Links
Building a New and Better Ankle
Date:9/2/2008

Improvements in Design Help Strengthen Total Ankle Replacements

ROSEMONT, Ill., Sept. 2 /PRNewswire-USNewswire/ -- Some form of total ankle replacements (TAR), have been available to patients in the United States since first arriving in the marketplace more than 30 years ago. These implants have gone through several design evolution phases. A review article published in the September 2008 issue of the Journal of the American Academy of Orthopaedic Surgeons (http://www.jaaos.org/) discusses the different types of total ankle replacement implants available now, both in the United States and abroad, and explains how vast improvements in their design are helping to advance the field and bring relief to patients.

"When we started off, the ankles we used in this country included just two components and we had to use bone cement to fix them and basically they all failed," said Andrea Cracchiolo, MD, lead author of the article and Director of the Adult Foot and Ankle section at UCLA Medical Center. "The difference between the first generation implants and those today is that you don't need to use bone cement. The surfaces are such that the bone will grow into the joint much like in total hip replacement."

Currently, four designs are approved by the Food and Drug Administration for use in the United States. All are two-component designs which are considered fixed implants. In many countries outside of the United States, surgeons have been using three-component ankles for several years. According to Dr. Cracchiolo, a three-component ankle may allow for more movement in the joint and may also be easier for orthopaedic surgeons to implant. Here in the U.S. a three-component device has been recommended for approval by the Food and Drug Administration. However, it could be late 2008 or longer before it will be made available to U.S. patients.

While total ankle replacement offers patients more mobility and movement compared to the option of fusion to repair the joint, not every patient is an ideal candidate. According to Dr. Cracchiolo, patients need a thorough evaluation from a qualified orthopaedic surgeon who feels the procedure may be appropriate. "Some patients have such deformity of the ankle or have an ankle that is so unstable that total ankle replacement is not indicated," explains Cracchiolo.

Signs that you may be a candidate for a total ankle replacement include:

-- Having a destroyed ankle, meaning the surfaces of the ankle are gone

-- Having advanced arthritis of the ankle

(http://orthoinfo.aaos.org/topic.cfm?topic=A00209#Cause)

-- The condition of your ankle is interfering with daily activities and

causing pain

Total ankle replacements can offer patients:

-- Better motion of the ankle compared to fusion

-- Protection in the small joints below and in front of the ankle from

developing arthritis

-- Relief of ankle pain

Currently, there are about 20 total ankle replacement implants worldwide that are either available or in the final stages of design. However the number of clinical studies involving such implants has been limited. Dr. Cracchiolo says, "Great care must go in to selecting not only the ideal patient, but also the implant that should be used. We need more long-term follow up clinical studies on implants here in the U.S. In addition, if patients are young, they should understand that the ankle replacement, just like the hip and knee, is not going to last a life time."

"As improvements in design continue to evolve, the goal is to develop total ankle replacements that are comparable to hips and knees in terms of quality and longevity," noted Dr. Cracchiolo.

Disclosure: Dr. Andrea Cracchiolo received no compensation for this review article and does not own stock in a commercial company or institution related directly or indirectly to the subject of this article. James K. DeOrio, MD, orthopaedic surgeon at Duke University, co-authored this review study.

For more information

JAAOS:

http://www.jaaos.org/

AAOS:

http://www6.aaos.org/news/Pemr/releases/release_boiler.cfm?category=8&r eleasen

um=702

AOFAS:

http://www.aofas.org/Scripts/4Disapi.dll/4DCGI/cms/review.html?Action=C MS_Docu
ment&DocID=124&MenuKey=123

orthoinfo.org:

http://www.orthoinfo.org/

For more information, contact:

Catherine Dolf: 847 384-4034, 847-894-9112

dolf@aaos.org

Lauren Pearson: 847 384-4031, 224-374-8610

lpearson@aaos.org


'/>"/>
SOURCE American Academy of Orthopaedic Surgeons
Copyright©2008 PR Newswire.
All rights reserved

Related medicine technology :

1. On World AIDS Day, CHF International Calls for Community Mobilization and Local Capacity Building to Fight HIV/AIDS
2. Findings on Bladder-Brain Link May Point to Better Treatments for Problems in Sleep, Attention
3. Head-to-Head Study Demonstrates Focalin(R) XR Offers Faster and Better Symptom Control than Concerta(R)1 in Early Part of ADHD Patients Day
4. Data Presented at Annual Meeting of Japanese Society of Interventional Cardiology Demonstrate OrbusNeichs Genous(TM) Bio-engineered R Stent(TM) Has Better Outcomes When Compared to Drug-Eluting Stents
5. Halozyme Therapeutics Announces Phase I Clinical Trial Results Demonstrating that the Combination of Recombinant Human Hyaluronidase (rHuPH20) With Humulin R(R) and with Humalog(R) Yields Faster, More Physiologic Insulin Kinetics and Better Predictability
6. Patients With Asthma and Seasonal Allergies Respond Better to Advair(R) for Their Asthma Than Singulair(TM)
7. Study in JAMA Shows Patients Treated With Abbotts XIENCE(TM) V Drug Eluting Stent Experience Better Outcomes Than Patients Treated With Market-Leading Drug Eluting Stent
8. In Blood Vessel Stents, Innovative Materials Allow Better Control, Delivery of Gene Therapy
9. Phreesia Announces Clinical Initiative to Better Manage Symptoms of Parkinsons Disease
10. Study Shows Once-Yearly Reclast Better than Risedronate at Increasing Bone Mass in Patients With Osteoporosis Caused by Glucocorticoids
11. Research Presented at ISHLT Shows Promise of Addressing Critical Organ Shortage and Better Organ Preservation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... -- Research and Markets has announced the addition ... report to their offering. ... The World Market for Companion Diagnostics covers the world ... in the report includes the following: , ... by Region (N. America, EU, ROW), 2015-2020 , World ...
(Date:6/23/2016)... , June 23, 2016  MedSource announced today ... its e-clinical software solution of choice.  This latest ... possible value to their clients by offering a ... preferred relationship establishes nowEDC as the EDC platform ... MedSource,s full-service clients.  "nowEDC has long been a ...
(Date:6/23/2016)... , June 23, 2016 Roche (SIX: RO, ... clearance for its Elecsys BRAHMS PCT (procalcitonin) assay as ... or septic shock. With this clearance, Roche is the ... fully integrated solution for sepsis risk assessment and management. ... bacterial infection and PCT levels in blood can aid ...
Breaking Medicine Technology:
(Date:6/24/2016)... ... ... Topical BioMedics, Inc, makers of Topricin and MyPainAway Pain Relief Products, join The ‘Business for ... $12 an hour by 2020 and then adjusting it yearly to increase at the same ... wage, assure the wage floor does not erode again, and make future increases more predictable. ...
(Date:6/24/2016)... ... June 24, 2016 , ... EB Medicine presented its first-ever ... Medicine conference in Ponte Vedra Beach, FL. The awards honor the outstanding work ... Practice and Pediatric Emergency Medicine Practice. , “With this award, we recognize ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... ... client, The Grove Investment Group (TGIG), has initiated cultivation and processing operations at ... Las Vegas and Pahrump, Nevada. , Puradigm is the manufacturer of a complete ...
(Date:6/24/2016)... ... June 24, 2016 , ... National recruitment firm ... sciences executive with extensive sequencing and genomics experience, as Vice President of North American ... Hill will be responsible for leading the sales team in the commercialization of the ...
(Date:6/24/2016)... ... June 24, 2016 , ... Today, MTI-GlobalStem, ... (iPS) cells and other difficult to transfect cells, announces its launch of the ... G9™ Gene Editing System is a complete system for culturing and transfecting ...
Breaking Medicine News(10 mins):